<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE us-patent-application SYSTEM "us-patent-application-v43-2012-12-04.dtd" [ ]><us-patent-application lang="EN" dtd-version="v4.3 2012-12-04" file="US20140005163A1-20140102.XML" status="PRODUCTION" id="us-patent-application" country="US" date-produced="20131218" date-publ="20140102"><us-bibliographic-data-application lang="EN" country="US"><publication-reference><document-id><country>US</country><doc-number>20140005163</doc-number><kind>A1</kind><date>20140102</date></document-id></publication-reference><application-reference appl-type="utility"><document-id><country>US</country><doc-number>13901849</doc-number><date>20130524</date></document-id></application-reference><us-application-series-code>13</us-application-series-code><classifications-ipcr><classification-ipcr><ipc-version-indicator><date>20060101</date></ipc-version-indicator><classification-level>A</classification-level><section>C</section><class>07</class><subclass>D</subclass><main-group>471</main-group><subgroup>04</subgroup><symbol-position>F</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source></classification-ipcr><classification-ipcr><ipc-version-indicator><date>20060101</date></ipc-version-indicator><classification-level>A</classification-level><section>C</section><class>07</class><subclass>D</subclass><main-group>498</main-group><subgroup>04</subgroup><symbol-position>L</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source></classification-ipcr></classifications-ipcr><classifications-cpc><main-cpc><classification-cpc><cpc-version-indicator><date>20130101</date></cpc-version-indicator><section>C</section><class>07</class><subclass>D</subclass><main-group>471</main-group><subgroup>04</subgroup><symbol-position>F</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source><scheme-origination-code>C</scheme-origination-code></classification-cpc></main-cpc><further-cpc><classification-cpc><cpc-version-indicator><date>20130101</date></cpc-version-indicator><section>C</section><class>07</class><subclass>D</subclass><main-group>498</main-group><subgroup>04</subgroup><symbol-position>L</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source><scheme-origination-code>C</scheme-origination-code></classification-cpc></further-cpc></classifications-cpc><classification-national><country>US</country><main-classification>51421018</main-classification><further-classification>51421021</further-classification><further-classification>5142305</further-classification><further-classification>5142328</further-classification><further-classification>51425303</further-classification><further-classification>51425505</further-classification><further-classification>514256</further-classification><further-classification>514274</further-classification><further-classification>514275</further-classification><further-classification>514293</further-classification><further-classification>544 91</further-classification><further-classification>544105</further-classification><further-classification>544126</further-classification><further-classification>544316</further-classification><further-classification>544331</further-classification><further-classification>544333</further-classification><further-classification>544361</further-classification><further-classification>544405</further-classification><further-classification>546 82</further-classification></classification-national><invention-title id="d0e43">1H-IMIDAZO[4,5-C]QUINOLINONE DERIVATIVES</invention-title><us-related-documents><continuation><relation><parent-doc><document-id><country>US</country><doc-number>12792471</doc-number><date>20100602</date></document-id><parent-grant-document><document-id><country>US</country><doc-number>8476294</doc-number></document-id></parent-grant-document></parent-doc><child-doc><document-id><country>US</country><doc-number>13901849</doc-number></document-id></child-doc></relation></continuation></us-related-documents><us-parties><us-applicants><us-applicant sequence="00" app-type="applicant" designation="us-only"><addressbook><last-name>Furet</last-name><first-name>Pascal</first-name><address><city>Thann</city><country>FR</country></address></addressbook><residence><country>FR</country></residence></us-applicant><us-applicant sequence="01" app-type="applicant" designation="us-only"><addressbook><last-name>Kalthoff</last-name><first-name>Frank Stephan</first-name><address><city>Guntramsdorf</city><country>AT</country></address></addressbook><residence><country>AT</country></residence></us-applicant><us-applicant sequence="02" app-type="applicant" designation="us-only"><addressbook><last-name>Mah</last-name><first-name>Robert</first-name><address><city>Muttenz</city><country>CH</country></address></addressbook><residence><country>CH</country></residence></us-applicant><us-applicant sequence="03" app-type="applicant" designation="us-only"><addressbook><last-name>Ragot</last-name><first-name>Christian</first-name><address><city>Fontainemelon</city><country>CH</country></address></addressbook><residence><country>CH</country></residence></us-applicant><us-applicant sequence="04" app-type="applicant" designation="us-only"><addressbook><last-name>Stauffer</last-name><first-name>Frederic</first-name><address><city>Hesingue</city><country>FR</country></address></addressbook><residence><country>FR</country></residence></us-applicant></us-applicants><inventors><inventor sequence="00" designation="us-only"><addressbook><last-name>Furet</last-name><first-name>Pascal</first-name><address><city>Thann</city><country>FR</country></address></addressbook></inventor><inventor sequence="01" designation="us-only"><addressbook><last-name>Kalthoff</last-name><first-name>Frank Stephan</first-name><address><city>Guntramsdorf</city><country>AT</country></address></addressbook></inventor><inventor sequence="02" designation="us-only"><addressbook><last-name>Mah</last-name><first-name>Robert</first-name><address><city>Muttenz</city><country>CH</country></address></addressbook></inventor><inventor sequence="03" designation="us-only"><addressbook><last-name>Ragot</last-name><first-name>Christian</first-name><address><city>Fontainemelon</city><country>CH</country></address></addressbook></inventor><inventor sequence="04" designation="us-only"><addressbook><last-name>Stauffer</last-name><first-name>Frederic</first-name><address><city>Hesingue</city><country>FR</country></address></addressbook></inventor></inventors></us-parties><assignees><assignee><addressbook><orgname>NOVARTIS AG</orgname><role>03</role><address><city>Basel</city><country>CH</country></address></addressbook></assignee></assignees></us-bibliographic-data-application><abstract id="abstract"><p id="p-0001" num="0000">The invention relates to the use of 1H-imidazo[4,5-c]quinolinone derivatives and salts thereof in the treatment of protein and/or lipid kinase dependent diseases and for the manufacture of pharmaceutical preparations for the treatment of said diseases; 1H-imidazo[4,5-c]quinolinone derivatives for use in the treatment of protein and/or lipid kinase dependent diseases; a method of treatment against said diseases, comprising administering the 1H-imidazo[4,5-c]quinolinone derivatives to a warm-blooded animal, especially a human; pharmaceutical preparations comprising an 1H-imidazo[4,5-c]quinolinone derivative, especially for the treatment of a protein and/or lipid kinase dependent disease; novel 1H-imidazo[4,5-c]quinolinone derivatives; and a process for the preparation of the novel 1H-imidazo[4,5-c]quinolinone derivatives.</p></abstract></us-patent-application>